References
- National Institutes of Health Revitalization Act of 1993, 103 U.S.C. Pub.L. 103-43 (1993).
- Geller SE, Koch AR, Roesch P, Filut A, Hallgren E, Carnes M. The more things change, the more they stay the same: a Study to evaluate compliance with inclusion and assessment of women and minorities in randomized controlled trials. Acad Med. 2018;93(4):630–635.
- Golden LC, Voskuhl R. The importance of studying sex differences in disease: the example of multiple sclerosis. J Neurosci Res. 2017;95(1–2):633–643.
- Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation. 2011;124(19):2145–2154.
- Riecher-Rössler A. Sex and gender differences in mental disorders. Lancet Psychiatry. 2017;4(1):8–9.
- Mack KA, Jones CM, Paulozzi LJ. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women–United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013;62(26):537–542.
- Mazure CM, Fiellin DA. Women and opioids: something different is happening here. The Lancet. 2018;392(10141):9–11.
- Office on Women’s Health (US). Final report: opioid use, misuse, and overdose in women. U.S. Dept. of Health and Human Services. https://www.womenshealth.gov/files/documents/final-report-opioid-508.pdf. Published July 19, 2017. Accessed April 3, 2020.
- An assessment of opioid-related deaths in Massachusetts (2013-2014). Massachusetts Department of Public Health. https://www.mass.gov/doc/legislative-report-chapter-55-opioid-overdose-study-september-2016/download. Published September 2016. Accessed March 23, 2020.
- Greenfield SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1–21.
- Evans EA, Goff SL, Upchurch DM, Grella CE. Childhood adversity and mental health comorbidity in men and women with opioid use disorders. Addict Behav. 2020;102:106149.
- Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services (N-SSATS). 2018. Data on substance abuse treatment facilities. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSSATS-2018.pdf. Published September 2019. Accessed April 13, 2020.
- Becker JB, Mazure CM. The federal plan for health science and technology's response to the opioid crisis: understanding sex and gender differences as part of the solution is overlooked. Biol Sex Differ. 2019;10(1):3.
- 2018 Opioid overdose deaths by gender. Kaiser Family Foundation analysis of Centers for Disease Control and Prevention WONDER Online Database, National Center for Health Statistics. https://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-gender/?dataView=2¤tTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Published February 2020. Accessed April 10, 2020.
- Centers for Disease Control and Prevention. 2019 Annual surveillance report of drug-related risks and outcomes — United States Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-report.pdf. Published November 1, 2019. Accessed April 9, 2020.
- Chou R, Korthuis PT, McCarty D, et al. Management of suspected opioid overdose with naloxone by emergency medical services personnel. Agency for Healthcare Research and Quality Publication No. 17(18)-EHC025-EF. https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/cer-193-naloxone-final_1.pdf. Published November 2017. Accessed February 16, 2021.
- Levy B, Spelke B, Paulozzi LJ, et al. Recognition and response to opioid overdose deaths-New Mexico, 2012. Drug Alcohol Depend. 2016;167:29–35.
- Morizio KM, Baum RA, Dugan A, Martin JE, Bailey AM. Characterization and management of patients with heroin versus nonheroin opioid overdoses: experience at an academic medical center. Pharmacotherapy. 2017;37(7):781–790.
- Banta-Green CJ, Coffin PO, Schoeppe JA, Merrill JO, Whiteside LK, Ebersol AK. Heroin and pharmaceutical opioid overdose events: emergency medical response characteristics. Drug Alcohol Depend. 2017;178:1–6.
- Ray BR, Lowder EM, Kivisto AJ, Phalen P, Gil H. EMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, Indiana. Addiction. 2018;113(12):2271–2279.
- Cash RE, Kinsman J, Crowe RP, Rivard MK, Faul M, Panchal AR. Naloxone administration frequency during emergency medical service events – United States, 2012-2016. MMWR Morb Mortal Wkly Rep. 2018;67(31):850–853.
- Faul M, Lurie P, Kinsman JM, Dailey MW, Crabaugh C, Sasser SM. Multiple naloxone administrations among emergency medical service providers is increasing. Prehosp Emerg Care. 2017;21(4):411–419.
- Sumner SA, Mercado-Crespo MC, Spelke MB, et al. Use of naloxone by emergency medical services during opioid drug overdose resuscitation efforts. Prehosp Emerg Care. 2016;20(2):220–225.
- Hamberg K. Gender bias in medicine. Womens Health. 2008;4(3):237–243.
- Massachusetts Office of Emergency Medical Services. Administrative requirement manual: statewide EMS minimum data set. Massachusetts Department of Public Health; https://www.mass.gov/files/documents/2018/12/17/ar-5-403-final.pdf. Published February 2019. Accessed April 9, 2020.
- MA opioid-related EMS incidents 2013-2019. Massachusetts Department of Public Health. https://www.mass.gov/doc/emergency-medical-services-data-june-2020/download. Published June 2020. Accessed February 16, 2021.
- Massachusetts Office of Emergency Medical Services. Administrative requirement manual: minimum standards for first responder training in first aid, epinephrine auto-injector and naloxone use. Massachusetts Department of Public Health. https://www.mass.gov/doc/ar-2-100-minimum-standards-for-first-responder-training-in-first-aid-epinephrine-auto-0/download. Published December 2016. Accessed on April 9, 2020.
- Opioid-related overdose deaths, all intents, MA residents-demographic data highlights. Massachusetts Department of Public Health. https://www.mass.gov/doc/opioid-related-overdose-deaths-demographics-june-2020/download. Published June 2020. Accessed August 6, 2020.
- Lasher L, Rhodes J, Viner-Brown S. Identification and description of non-fatal opioid overdoses using Rhode Island EMS data, 2016–2018. Rhode Island Medical Journal. http://www.rimed.org/rimedicaljournal/2019/03/2019-03-41-health-lasher.pdf. Published March 2019. Accessed March 25, 2020.
- Lewis JF, Zeger SL, Li X, et al. Gender differences in the quality of EMS care nationwide for chest pain and out-of-hospital cardiac arrest. Womens Health Issues. 2019;29(2):116–124.
- Data brief: overdose education and naloxone distribution programs. Massachusetts Department of Public Health. https://www.mass.gov/doc/data-brief-overdose-education-and-naloxone-distribution-programs/download. Published August 2019. Accessed April 30, 2020.
- Lynn RR, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018;9(1):63–88.